SYSTEMS, METHODS, AND DEVICES FOR EX VIVO ANALYSIS OF RESECTED TISSUE SAMPLES
US Application 62/988,783
Filed on 2020-03-12
Filed on 2020-03-12
METHODS OF ISOLATING T-CELLS AND T-CELL RECEPTORS FROM TUMOR BY SINGLE-CELL ANALYSIS FOR IMMUNOTHERAPY
US Application 62/992,701
Filed on 2020-03-20
Filed on 2020-03-20
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION
US Application 62/975,544
Filed on 2020-02-12
Filed on 2020-02-12
RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER
US Application 62/966,204
Filed on 2020-01-27
Filed on 2020-01-27
INHIBITION OF ACTIVE TUMOR DEFENSE TO IMPROVE IMMUNOTHERAPY EFFICACY AND USES THEREOF
US Application 62/956,955
Filed on 2020-01-03
Filed on 2020-01-03
CODEFACS AND LIRICS PIPELINES FOR BULK EXPRESSION DECONVOLUTION
US Application 62/940,755
Filed on 2019-11-26
Filed on 2019-11-26
KRAS Peptide Vaccine Compositions And Method Of Use
US Application 62/454,270
Filed on 2017-02-03
Filed on 2017-02-03
Altering The Humoral Immune Hierarchy
US Application 62/935,016
Filed on 2019-11-13
Filed on 2019-11-13
ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE
US Application 62/963,959
Filed on 2020-01-21
Filed on 2020-01-21
ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF
US Application 62/947,135
Filed on 2019-12-12
Filed on 2019-12-12